Gsa Capital Partners LLP Atri Cure, Inc. Transaction History

Gsa Capital Partners LLP

$1.11 Billion
Q1 2025

A detailed history of Gsa Capital Partners LLP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 71,761 shares of ATRC stock, worth $2.32 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

71,761

Previous 72,218 0.63%

Holding current value

$2.32 Million

Previous $2.21 Million 4.89%

% of portfolio

0.21%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	SELL	$30.4 - $42.4 $13,892 - $19,376	-457 Reduced 0.63%	71,761 $2.32 Million
Q4 2024 Feb 07, 2025	BUY	$27.02 - $38.2 $1.95 Million - $2.76 Million	72,218 New	72,218 $2.21 Million
Q2 2024 Aug 15, 2024	BUY	$19.86 - $29.09 $67,027 - $98,178	3,375 Added 9.42%	39,188 $892,000
Q1 2024 May 03, 2024	BUY	$28.21 - $37.78 $400,412 - $536,249	14,194 Added 65.66%	35,813 $1.09 Million
Q4 2023 Feb 16, 2024	SELL	$32.99 - $43.25 $146,607 - $192,203	-4,444 Reduced 17.05%	21,619 $771,000
Q3 2023 Nov 15, 2023	BUY	$41.12 - $57.73 $340,884 - $478,581	8,290 Added 46.64%	26,063 $1.14 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $262,617 - $322,102	6,494 Added 57.58%	17,773 $877,000
Q1 2023 May 12, 2023	BUY	$35.87 - $47.22 $404,577 - $532,594	11,279 New	11,279 $467,000
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $38,594 - $53,093	1,009 Added 5.84%	18,286 $715,000
Q2 2022 Aug 09, 2022	BUY	$35.1 - $66.01 $606,422 - $1.14 Million	17,277 New	17,277 $706,000
Q3 2021 Nov 12, 2021	SELL	$69.28 - $84.46 $433,623 - $528,635	-6,259 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$64.13 - $80.18 $63,809 - $79,779	-995 Reduced 13.72%	6,259 $497,000
Q1 2021 May 10, 2021	BUY	$53.79 - $66.98 $390,192 - $485,872	7,254 New	7,254 $475,000
Q4 2020 Feb 03, 2021	SELL	$34.56 - $57.55 $288,368 - $480,197	-8,344 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$38.36 - $46.91 $320,075 - $391,417	8,344 New	8,344 $333,000
Q1 2020 May 12, 2020	SELL	$24.49 - $43.84 $319,178 - $571,366	-13,033 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$24.06 - $32.51 $108,751 - $146,945	-4,520 Reduced 25.75%	13,033 $424,000
Q3 2019 Nov 12, 2019	SELL	$23.81 - $32.52 $69,501 - $94,925	-2,919 Reduced 14.26%	17,553 $438,000
Q2 2019 Aug 06, 2019	BUY	$26.85 - $30.74 $549,673 - $629,309	20,472 New	20,472 $611,000
Q4 2018 Feb 12, 2019	SELL	$26.66 - $34.85 $1.24 Million - $1.62 Million	-46,424 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$27.62 - $35.58 $562,619 - $724,764	20,370 Added 78.18%	46,424 $1.63 Million
Q2 2018 Aug 09, 2018	BUY	$19.65 - $30.28 $294,435 - $453,715	14,984 Added 135.36%	26,054 $705,000
Q1 2018 May 11, 2018	SELL	$15.05 - $21.03 $656,812 - $917,791	-43,642 Reduced 79.77%	11,070 $227,000
Q4 2017 Feb 14, 2018	BUY	$17.69 - $23.44 $967,855 - $1.28 Million	54,712	54,712 $998,000

Others Institutions Holding ATRC

# of Institutions

238

Shares Held

52M

Call Options Held

32.6K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.5B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Atri Cure, Inc. Transaction History